Fresenius to Reduce Stake in Fresenius Medical Care AG

Fresenius SE & Co. KGaA announced plans to decrease its ownership in Fresenius Medical Care AG (FME) from 32.2% to a minimum of 25% plus one share. The sale involves approximately 10.5 million shares, roughly 3.6% of FME’s capital, via an accelerated bookbuilding process. Bonds exchangeable into 10.5 million FME shares will also be issued. The final amounts will be determined post the bookbuilding process.

The proceeds aim to align with Fresenius's #FutureFresenius strategy, focusing on balance sheet strength, reduced leverage, and long-term shareholder value. Despite the reduction, Fresenius remains the largest FME shareholder and will continue to influence FME through board representation.